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Abstract: BACKGROUND The prevalence of persons who are born with primary and secondary male
sexual characteristics but feel that they are female (trans women) is ca. 5.48 per 100 000 males in
Germany. In this article, we provide a detailed overview of the currently available data on quality
of life after male-to-female sex reassignment surgery. METHODS This review is based on publications
retrieved by a systematic literature search that was carried out in the PubMed, EMBASE, Web of Science,
and PsycINFO databases in March 2017. RESULTS The 13 articles (11 quantitative and 2 mixed
quantitative/qualitative studies) that were found to be suitable for inclusion in this review contained
information on 1101 study participants. The number of trans women in each study ranged from 3 to
247. Their mean age was 39.9 years (range: 18-76). Seven different questionnaires were used to assess
postoperative quality of life. The findings of the studies permit the conclusion that sex reassignment
surgery beneficially affects emotional well- being, sexuality, and quality of life in general. In other
categories (e.g., ”freedom from pain”, ”fitness”, and ”energy”), some of the studies revealed worsening
after the operation. All of the studies were judged to be at moderate to high risk of bias. The drop-out
rates, insofar as they were given, ranged from 12% to 77% (median: 56%). CONCLUSION Current
studies indicate that quality of life improves after sex reassign- ment surgery. The available studies are
heterogeneous in design. In the future, prospective studies with standardized methods of assessing quality
of life and with longer follow-up times would be desirable.
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Original Article
Quality of Life Following Male-To-Female  
Sex Reassignment Surgery
Géraldine Weinforth, Richard Fakin, Pietro Giovanoli, David Garcia Nuñez
T
he term “gender incongruence” (GI) describes the 
situation in which a person does not identify with 
the gender they were assigned at birth on the basis 
of physical sexual characteristics and that they 
 consequently experience “a marked and persistent 
 incongruence between . . . experienced gender and the 
assigned sex” (1). The term trans women describes 
 persons with congenital primary and secondary male 
sexual characteristics (assigned male at birth) who feel/
identify as women. Trans men are persons who feel/
identify as men but who have primary and secondary fe-
male sexual  characteristics (assigned female at birth). 
Persons who fully identify with the sex/gender they 
were assigned at birth are known as cis women and cis 
men. 
A data analysis from 2000 showed a prevalence in 
Germany of 4.26 trans persons/100 000 population 
(5.48 trans women/100 000 of the male population 
and 3.12 trans men/100 000 of the female population) 
(2). We are not aware of any more recent data for 
 Germany.
If persons with gender incongruence develop clini-
cally relevant biopsychosocial suffering, they have 
gender dysphoria (GD), according to the DSM-5 
 classification (3). For many trans persons, physical 
transition is the best option for alleviating the symp-
toms of gender dysphoria (4). Sex/gender reassign-
ment hormone treatment as well as surgery have a 
central role in this setting (5). The latter comprise 
 surgical procedures involving the genitals (sex 
 reassignment surgery) (Box), the breasts, and the face 
and vocal cords, as well as hair epilation (6).
A US study showed that from 2000 to 2011, the 
rate of surgical sex reassignment measures among 
trans persons rose from 72% to 83.9% (7). These data 
move the question of the effectiveness of such oper-
ations increasingly into the focus of clinical attention 
and awareness (8–11).
In the context of evidence-based medicine, the con-
sensus is now that the success of medical procedures 
should not be studied merely in terms of objective re-
sults (survival and complication rates, measurements 
of functionality, etc), but that patients’ personal well-
being should be included in assessing the success of 
any procedure (12, 13). Review articles to date have 
shown that sex reassignment hormone treatment has a 
positive effect on the quality of life of trans persons 
(14, 15). By contrast, an overall assessment of quality 
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of life after sex reassignment surgery is so far lacking. 
In this article we will attempt to provide a review of 
current studies, and on this basis we will investigate 
the question of quality of life after sex reassignment 
surgery.
For the review to be as representative as possible, 
this article deals with trans women only, whose inci-
dence is notably higher than that of trans men (0.41 
male to female/100 000 total male population in 
 Germany and 0.26 female to male/100 000 total 
 female population in Germany) (2).
Methods
We conducted as systematic literature search in 
PubMed, EMBASE, Web of Science, and PsycINFO in 
March 2017. GW and DGN independently undertook 
the article search on the basis of the recommendations 
summarized in the PRISMA statement (16). Details of 
the methods are described in the eMethods section.
Inclusion criteria
We included only articles on the subject of the quality 
of life of trans women after sex reassignment surgery. 
GW, RF, and DGN operationalized (eTable 1) the 
search terms in an iterative process according to the 
PICO method (e1) and set out a search string (eTable 
2).
Exclusion criteria
 Among others, we excluded studies that did not focus 
exclusively on trans persons or that didn’t collect data 
on quality of life by using a standardized questionnaire. 
We also excluded studies in underage trans people.
Screening process
The Figure shows the study selection process.
Study analysis
All included articles are non-randomized studies with 
an evidence level of III (e2). In the case of studies that 
reported on the quality of life of trans women as well as 
trans men (17–21) we ensured that the data for trans 
women were evaluated separately or that the ratio of 
M–F/F–M favored trans women. Table 1 shows further 
key study data; Table 2 shows the quality character-
istics of the studies. 
Results
The studies made use of the following instruments:
● 6 studies used the Short Form 36 Health Survey 
(SF-36) (18, 20, 22–25);
● 2 studies used the World Health Organization’s 
Quality of Life 100 questionnaire (WHOQOL-100) 
(17, 26); 
● 2 studies used the Subjective Happiness Scale 
(SHS) in combination with the Satisfaction with 
Life Scale (SWLS) and the Cantrils Ladder of Life 
Scale (CLLS) (27, 28);
● 2 studies used the FLZ questionnaire (Fragebogen 
zur Lebenszufriedenheit) (21, 29); and
● 1 study used the King’s Health Questionnaire 
(KHQ) (19). 
None of the questionnaires constitutes an investi-
gative tool that is specifically tailored to trans per-
sons. Table 3 shows the result scales. Table 2 shows 
the confounding variables and, as far as it is possible 
to assess this, the risk of bias.
Quality of life
The SF-36 and WHOQOL-100 are validated, reliable 
and disease–non-specific instruments for measuring 
health-related quality of life (30, 31). They can be used 
to gain information on the individual health status and 
allow for observing disease-related stresses over time. 
The questionnaires collect data on numerous aspects of 
daily life, which in their totality reflect quality of life. 
They are used internationally and therefore make 
 cross-cultural studies an option (32). 
Studies that used the SF-36 to answer the question 
of postoperative quality of life (18, 20, 22–25) 
 observed after sex reassignment surgery an improve-
ment in “social functioning”, “physical” and 
 “emotional role functioning”, “general health percep-
tions”, “vitality”, and “mental health” (p = 0.025 to 
p >0.05). In two of these studies (22, 24), “mental 
health” in trans women after sex reassignment sur-
gery did not differ significantly from the standard 
sample. This explains the formally non-significant 
BOX
Principle of male-to-female sex reassignment surgery
● Bilateral orchiectomy
● Preparation of the glans (head) of the penis with the complete neurovascular 
bundle
● Preparation of the urethra
● Subtotal resection of the cavernous bodies (corpora cavernosa) and the 
 corpus spongiosum of the penis
● Vaginoplasty
–  Preparation of the neovaginal space in the perineal area between rectum 
and urethra/bladder
– Lining the space by using
 – Penile inversion vaginoplasty (pedicle flap from the skin of the penal 
shaft: gold standard)
 – If required, use of free split-thickness skin grafts
 – Alternatively, construction of a neo-vagina using intestinal vagino -
plasty: 
  – In selected cases, this is the primary indication—for example, in 
trans women with penoscrotal hypoplasia or at the patient’s wish 
(for better natural secretion). 
  – This procedure can also be used as a secondary intervention in 
patients after unsatisfactory penile inversion vaginoplasty.
● Construction of a neo-clitoris from the glans (head) of the penis
● Construction of a urethral neo-meatus after urethral shortening as required
● Construction of labia from the remaining scrotal skin, possibly also labia 
 minora
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result. Ainsworth and Spiegel (22) showed that trans 
women without surgical intervention when compared 
indirectly with cis women from the SF-36 standard 
sample reported significantly poorer “mental health” 
(39.5 vs 48.9; p <0.05). Lindqvist et al. (23) and 
Weyers et al. (24) found an improvement in “self-
perceived health” in the first postoperative year 
(p <0.05 and p <0.009), which deteriorated later but 
did not fall as low as its original score (p <0.0001). 
Furthermore, the studies concluded that “physical 
pain” increased postoperatively and “physical func-
tioning” decreased; the postoperative follow-up peri-
ods varied between 3 months (18) and 5 years (23). 
According to Lindqvist et al. (23), “physical pain” in 
trans women five years postoperatively was com-
parable to that in the standard population (72.5 vs 
72.7; SD 26.5).
Studies that used the WHOQOL-100 came up with 
the following results: Cardoso da Silva et al. (26) 
 observed postoperatively an increase in “sexual 
 activity” (p = 0.000) compared with the preoperative 
evaluation (prospective study design). Furthermore 
they found a postoperative improvement in the 
 “psychological domain” (p = 0.041) and “social rela-
tionships” (p = 0.007), but a deterioration in “physi-
cal health” (p = 0.002) and “independence” 
(p = 0.031). Accordingly, deteriorations were seen in 
the areas of “energy” and “fatigue”, “sleep”, 
“negative feelings”, “mobility”, and “activities of 
daily living” (p <0.05). Castellano et al. (17) found 
after sex reassignment surgery for the group of trans 
women compared with the group of cis women no 
significant differences  relating to “sexual activity” 
(65.85 vs 66.28; p >0.05), “body image” (64.64 vs 
65.47; p >0.05), and the “quality of life score” (67.87 
vs 69.49; p >0.05).
Quality of life and urinary incontinence
The King’s Health Questionnaire (KHQ) is a validated 
questionnaire for evaluating the impact of urinary 
 incontinence on quality of life (33), a topic of central 
importance for trans persons (34). This questionnaire 
interrogates the quality of life domains always in 
 association with urinary incontinence as the main prob-
lem. Kuhn et al. (19) showed that “general health” in 
trans persons was experienced as poorer to a relevant 
extent (Cohen’s d = 4.126; p = 0.019), and “physical” 
(d = −7.972; p <0.0001) and “personal limitations” 
(d = −7.016; p <0.001) were experienced to a greater 
extent. In contrast to this, trans persons felt less limited 
in terms of “role limitation” (d = 3.311; p = 0.046). For 
“emotions”, “sleep”, “incontinence”, and “symptom se-
verity”, the differences to the control group did not 
reach significance. The control group consisted of cis 
women who had undergone abdominopelvic surgery. 
The evaluation of the visual analogue scale (VAS) 
showed a lower (d = 14.136; p <0.0001) degree of 
 general life satisfaction in the group of trans persons.
Life satisfaction
The SHS (35), SWLS (36), and CLLS (37) are vali-
dated and internationally used visual analogue scales to 
evaluate life satisfaction. The SHS evaluates individual 
happiness and associated physical, mental, and social 
wellbeing (35). The SWLS was used as a short-form 
scale in the cited studies (also known as L-1) and in-
cluded only the question on general life satisfaction 
(36). The CLLS evaluates emotional wellbeing associ-
ated with life satisfaction as well as subjective health 
(37).
Studies that used the SHS, SWLS, and CLLS (27, 
28) to evaluate postoperative life satisfaction reported 
a high degree of “subjective happiness” (5.6; SD 1.4 
FIGURE
Flow chart illustrating the study selection process
Articles excluded after title review (n = 270) 
Articles excluded after review of the abstract (n = 28) 
Articles excluded after review of full text (n = 14)
Studies included in systematic review (n = 13); of which 
quantitative studies: n = 11, mixed method quantitative/qualitative studies: n = 2 
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Articles identified in  
Web of Science  
(n  = 75) 
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Key data from included studies
*1Numbers of study participants after removal of dropouts (Table 2); exception: Lindqvist et al. (23), see Table 2 
*2 M–F, male-to-female; F–M, female to male, sex reassignment surgery
Authors
(reference) 
Ainsworth et al. (22)
Bouman et al. (27)
Cardoso da Silva et al. (26)
Castellano et al. (17)
Jokic-Begic et al. (18)
Kuhn et al. (19)
Lindqvist et al. (23)
Papadopulos et al. (29)
Parola et al. (20)
van der Sluis et al. (28)
Weyers et al. (24)
Yang et al. (25)
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n = 47
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Quality characteristics of the studies
*1 M–F male to female; F–M female to male, reassignment surgery
*2 Prospective study design
*3 Of originally 190 participants, n = 160 (84.21%) completed the questionnaire preoperatively and n = 47 (24.73%) postoperatively 
*4 Out of a total of 190 study participants, n = 146 (76.84%) completed the questionnaire preoperatively, n = 108 (56.84%) 1 year postoperatively, n = 64 (33.68%) 3 years postoperatively, and n = 43 (22,63%) 5 years postoperatively. Most of the 190 participants com-















































 Non-respondents n = 6 (15.38%)
Lost to follow-up n = 1 (2.56%)
 Deceased n = 1 (2.56%)
—
Non-respondents n= 8 (11.76%)
Lost to follow-up n = 1 (12.5%)
Refused participation n = 1 (12.5%)
—
 Deceased or moved without changing  address and 
entry in residents‘ register
 Unavailable/incorrect phone number n = 38 (31.40%) 
 Refused participation n = 14 (11.57%)
 Quesionnaire not completed n = 22 (18.18%)
—
Non-respondents n = 6 (25%)
Lost to follow-up n = 3 (12.5%) 
Deceased n = 5 (20.84%) 
 Refused participation n = 1 (4.16%)
Non-respondents n= 17 (24.29%) 
 Refused participation n=3 (4.29%)
—
Non-respondents n = 45 (50%) 
Incomplete questionnaire n = 3 (3.34%) 
Inclusion criteria not met n = 2 (2.23%) 
Confounding variables
n = 25 (10.12%) M–F*1 had sex reassignment surgery
n = 47 (19.02%) had sex reassignment surgery and facial 
 feminiza tion surgery
n = 28 (11.3%) had facial feminization surgery
n = 147 (59.51%) had no surgery
Time of survey not stated, hormone therapy
27 M–F (= 87.1%) completed the QoL questionnaire,  
hormone therapy
Dropout rate very high, no reasons given
31 M–F (65.95%) had corrective surgery, hormone therapy
Only the domain general quality of life score and subdomains 
 sexuality and body were requested, hormone therapy
Very small study population, socioeconomic and clinical circum-
stances, psychotherapy, hormone therapy
No detail on interventions in the control group,
no separate data analysis for M–F and F–M, hormone therapy
 Very high dropout rate,  only 17 patients completed the question-
naire at  all 4 follow-up points,  hormone therapy
Inclusion criteria: only patients who had had corrective surgery or 






n = 73 (34.92%) had facial feminization surgery
n = 43 (20.57%) had breast augmentation surgery
Only n = 4 (1.91%) had sex reassignment surgery
Socioeconomic and clinical circumstances
Hormone therapy in only n = 37 (17.7%)
Absolute values from FLZ questionnaire not shown, only p-values 
reported, no separate evaluation of FLZ questionnaire for F–M and 
M–F, hormone therapy
Estimated risk of bias (e3) 
Moderate to high:  
selection bias, classification bias,  
bias owing to deviations in interventions
Moderate to high: selection bias
Moderate to high: selection bias, attrition bias
Moderate to high: selection bias
Moderate: detection bias 
Moderate to high: selection bias
 Moderate to high: selection bias,  
bias owing to deviations in interventions
Moderate to high: selection bias, attrition bias
Moderate to high: selection bias
Moderate to high: selection bias
Moderate to high: selection bias
Moderate to high: selection bias
Moderate to high: selection bias,  
bias owing to deviations in interventions 
Moderate to high: selection bias
D
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and 5.9; SD 0.6), of “satisfaction with life“ (27.7; SD 
5.8 and 27.1; SD 2.1) and “subjective wellbeing” (8.0 
[range: 4–10] and 7.9; SD 0.7) in trans women after 
intestinal vaginoplasty. The studies cited earlier differ 
with regard to the following items: Bouman et al. (27) 
studied a population of young trans women (mean 
age: 19.1 years) with penoscrotal hypoplasia after 
 primary laparoscopic intestinal vaginoplasty. The 
study participants had received puberty blockers 
 during their transition therapy, which resulted in 
 penoscrotal hypoplasia and made penile inversion 
vaginoplasty (Box) impossible. Van der Sluis et al. 
(28) studied an older population (mean age: 58 years) 
of trans women after secondary intestinal vagino -
plasty—that is, patients who required secondary 
 intestinal reconstruction owing to vaginal stenosis or 
insufficient vaginal length after penile inversion vag-
inoplasty. The postoperative follow-up period varied 
between 1–7.5 years (27) and 17.2–34.3 years (28). In 
spite of the different patient populations, these studies 
found that sex reassignment surgery had a positive 
 effect on life satisfaction.
The FLZ is a validated multidimensional question-
naire for evaluating individual general life satisfac-
tion (38). It is used in life quality and rehabilitation 
research and enables the recording of changes if 
 administered repeatedly. It is available in a German 
language version only; for this reason, its results 
apply only to German speaking populations.
Studies that used the FLZ questionnaire (21, 29) 
found that the postoperative life satisfaction of trans 
women in terms of “health” does not differ from that 
of the general population. Additionally, Papadopoulos 
et al. (29) found no differences for “friends”, 
 “hobbies”, “income”, “work”, and “relationship.” A 
subanalysis of the module “health” found postoper-
atively in both studies a relevant decrease in “fitness” 
(d = 0.521; p <0.001) and “energy” (d = 0.494; 
p <0.003). Zimmerman et al. (21) additionally found 
a significant decrease in “ability to relax/equilibrium” 
(p = 0.002), “fearlessness/absence of anxiety” 
(p = 0.015), and “absence of discomfort/pain” 
(p = 0.037). Both studies (21, 29) were retrospective 
surveys that were undertaken once only in a time 
 period between 6 months and 58 months post -
operatively. Papadopoulos et al. (29) included only 
subjects into the study who did not require any further 
corrective surgery after sex reassignment surgery or 
who had already undergone a second procedure for 
the purpose of minor corrections.
Discussion
Two prospective studies documented postoperatively a 
notable improvement in quality of life (23, 26). Four 
studies found that the life quality of trans women after 
sex reassignment surgery was no different from that of 
cis women (17, 20, 22, 24). Sex reassignment surgery 
has also been shown to have a positive effect on life 
 satisfaction (27, 28)—the exception was urinary in-
continence, in which case life satisfaction dropped (19). 
Lindqvist et al. (23) and Weyers et al. (24) observed an 
improvement in self-perceived health in the first post-
operative year, which then drops, albeit not all the way 
down to its original level. This is consistent with the 
honeymoon phase described by De Cuypere et al. (39), 
which has been described as a euphoric period in the 
first year after surgery. Several studies (18, 20–25) 
showed that physical pain increased after surgery and 
physical functioning deteriorated. This is easily 
 explained by the surgery itself, however; the postoper-
ative follow-up periods in these studies varied between 
3 months (18) and 5 years (23).
Altogether the study results imply that sex 
 reassignment surgery has an overall positive effect on 
partial aspects, such as mental health, sexuality, life 
satisfaction, and quality of life.
These results were confirmed by Barone et al. (40) 
and Murad et al. (15) in their review articles, which 
were published in 2017 and 2010, respectively. 
 Barone et al. (40) in a systematic review evaluated pa-
tient reported results after sex reassignment surgery; 
among others, regarding life satisfaction. Murad et al. 
(15) in a meta-analysis focused on quality of life and 
psychosocial health after hormone therapy (main 
 aspect) and sex reassignment surgery. In sum, both 
studies found improvements in quality of life and life 
satisfaction after sex reassignment surgery, and an 
 improvement at the psychosocial level. Hess et al. 
TABLE 3
Simplified result scales of the SF-36, WHOQOL-100, SHS, SWLS, and CLLS instruments*
*For the studies referenced in parentheses, it was not possible to calculate effect sizes
Questionnaire





Composition of score values
36 items
100 items 
VAS, 4 items on a 7 point Likert scale
VAS, 5 items on a 7 point Likert scale
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(11) concluded that the study participants benefited 
from sex reassignment surgery—they too found high 
rates of satisfaction postoperatively in Germany.
As sex reassignment surgery often constitutes the 
final step of sex reassignment measures, hormone 
therapy as well as accompanying psychotherapy may 
have had a confounding effect. Not all studies 
 adjusted for confounding factors. A lack of random -
ization and control or the use of a matched control 
group (17, 19) in the studies also introduced methodo-
logical bias (Table 2). Furthermore, the high dropout 
rates of 12% (17) to 77% (23) (median: 56%), which 
are mainly due to non-respondents, should be 
 assessed critically. In our experience, however, the 
patient population of trans women is often reticent 
and is not interested in study participation because of 
personal reasons (“to not be reminded of that time”). 
Other authors have shared this observation (18, 24), 
which may also explain the occasionally high dropout 
rates. There is also the possibility that dissatisfied 
 patients were among the dropouts. Owing to socio -
economic and clinical conditions, the studies from 
Croatia (18) and China (25) need to be evaluated sep-
arately. On the one hand, the authors of both studies 
draw attention to the public’s lack of awareness and 
understanding (and the associated psychological 
stress for trans women) in these countries, and, on the 
other hand, statutory sickness funds did not cover the 
costs of all treatments, which were therefore access-
ible to only few patients. This explains the notably 
lower participant numbers of 3 (18) and 4 (25) male-
to-female transitions after sex reassignment surgery. 
None of the included studies reported potential 
 suicide rates.
The strength of this review lies in the fact that we 
included only studies that used standardized question-
naires. Tests (such as the SF-36 or WHOQOL-100) 
represent validated and reliable measuring instru-
ments, for some of which reference standard 
 populations exist, and they enable international and 
intercultural comparison. Furthermore, standardized 
questionnaires have the advantage of a high degree of 
objectivity in terms of conducting, evaluating, and 
 interpreting studies.
Conclusion
The available study data show that sex reassignment 
surgery has a positive effect on partial aspects—such as 
mental health/wellbeing, sexuality, and life satisfac-
tion—as well as on quality of life overall.
It should be noted that the studies are almost 
 exclusively retrospective analyses of mostly uncon-
trolled and small cohorts, for which no valid or 
 specific measuring instruments are available to date. 
Because of the high dropout and non-response rates, 
the current data should be interpreted with caution.
In spite of the essentially positive results, the data 
are not satisfactory at this point in time. Due to the 
studies’ limited follow-up times, no conclusions can 
be drawn as yet about the long term consequences of 
such procedures. Furthermore, many studies did not 
use standardized questionnaires and/or scores, which 
makes comparisons between individual studies 
 difficult.
Key messages
● Trans persons suffer from the tension between their biologically characterized body 
and their experienced sex/gender.
● Undergoing medical and/or social transition seems for many trans persons the best 
possible solution for alleviating their gender dysphoria symptoms.
● Results from studies imply that sex reassignment surgery on the one hand has 
 positive effects in terms of partial aspects of quality of life, such as mental health, 
sexuality, and life satisfaction, and, on the other hand, on quality of life overall.
● Because of the studies’ high dropout rates (12–77%; median 56%), the results 
should be interpreted with caution.
● The studies did not include information on potential suicide rates.
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Additional points regarding the study method
We conducted a systematic key word guided literature search of four databases (PubMed, 
 EMBASE, Web of Science, PsycINFO) in March 2017 in order to identify the current medical 
literature relating to our research question. Among the search terms we used were “transsexual-
ism”, “reassignment surgery”, and “quality of life” (eTable 1). The article search was adapted 
to the technical requirements (for example, the option of using MeSH terms) of each database 
and undertaken by GW and DGN independently, supported by the recommendations summa -
rized in the PRISMA statement (16).
Inclusion criteria
We included only articles that focused on the topic of the quality of life of trans women who 
had had sex reassignment surgery, independently of the studies’ population sizes and publi-
cation dates. GW, RF, and DGN operationalized the search terms by using an iterative process 
following the PICO method (e1) (eTable 1) and a search string was created with these (eTabelle 
2). The search for publications intentionally identified only studies reported in English or 
 German.
Exclusion criteria
Studies that did not exclusively focus on trans persons (for example, LGBT [= lesbian, gay, bi-
sexual, and transgender] studies) or that did not evaluate quality of life by using a standardized 
questionnaire were not considered. Furthermore, this review did not include review articles, 
published dissertations, nor congress presentations/commentaries. Studies of trans persons 
who were under age were excluded too.
Screening process
During the study selection process we excluded according to the mentioned criteria those 
studies that were not able to contribute to answering our research question (Figure). Fur-
thermore, we searched the reference lists of all selected articles in order to be able to include 
further studies that were not found in the databases. This yielded four additional studies that 
met the inclusion criteria. In a parallel and independent process, DGN checked the results of 
this search. In cases where discrepancies were found, a solution pertaining to the inclusion of 
the relevant study was found by consensus.
Study analysis
After the study selection process we viewed full-text articles and collated important key study 
data (Table 1). According to the definitions in the PICO scheme (e1) we collated all relevant 
parameters from the individual studies in further full-text reviews. The first author extracted 
the data, and DGN checked these in a second, independent process. All included articles are 
non-randomized studies of evidence level III (e2). Some studies (17–21) reported on the 
quality of life of trans women as well as trans men. In these cases we ensured that the data 
evaluation for trans women was done separately or the ratio M–F/F–M was in favor of trans 
women. Where information was lacking or lack of clarity existed in individual studies, we 
 contacted the authors. Table 2 shows the quality characteristics of the included studies.
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eTABLE 1
Search terms*





transsexualism, transgender, transgenderism, 
gender identity disorder, transgender persons, sexual transition, 
gender transition, male-to-female, gender non-conform,  
gender-transform, gender incongruence
reassignment surgery, sex reassignment,  
sex reassignment surgery, sex change,  
gender reassignment surgery, sex reassignment operation,  
gender transformation operation, penile inversion vaginoplasty
–
quality of life 
eTABLE 2
Search string*




1. Catch phrase 
search (MeSH 
terms)
2. Key word search
Web of Science
“transsexualism” OR “transgender” OR  
“transgenderism” AND (“reassignment surgery” OR
“sex reassignment”) AND “quality of life”
(DE “Transgender” OR DE “Transsexualism”  
OR DE “Gender Identity Disorder”) AND  
(DE “Sex Change” OR DE “Surgery” OR  
“reassignment surgery” OR “sex reassignment”) AND  
“quality of life”
(“Transsexualism”[Mesh]) AND  
(“Sex Reassignment Surgery”[Mesh]) AND  
(“Quality of Life”[Mesh])
((“Transgender Persons”[Mesh]) OR  
“Transsexualism”[Mesh]) AND (“Quality of Life”[Mesh])
(“Quality of life”) AND (“gender reassignment surgery” OR 
“sex reassignment operation” OR  
“gender transformation operation” OR 
 “sex reassignment surgery” OR  
“penile inversion vaginoplasty” AND sex* AND  
chang* OR sex* AND reassign* OR gender-reassign*) AND 
(gender-dysphor* OR transsex* OR gender-nonconform* 
OR gender-non-conform* OR transgend* OR  
transident* OR gender-incongruence OR gender-varian* 
OR gender-transform* OR gender-identity-disorder* OR  
sexual-transition OR gender-transition OR sexual-dysphor* 
OR transvest* OR autogyn* OR trans-sex* OR trans-gend* 
OR trans-ident* OR “male-to-female”)
(gender-dysphor* OR transsex* OR gender-nonconform* 
OR gender-non-conform* OR trans-gend* OR trans-ident* 
OR gender-incongruence OR gender-varian* OR  
gender-transform* OR gender-identity-disorder* OR  
sexual-transition OR gender-transition OR sexual-dysphor* 
OR transvest* OR autogyn* OR trans-sex* OR trans-gend* 
OR trans-ident* OR “male-to-female”)
AND (“gender reassignment surgery” OR  
“sex reassignment operation” OR  
“gender transformation operation” OR  
“sex reassignment surgery” OR  
“penile inversion vaginoplasty” OR sex* chang* OR  
sex* reassign* OR gender-reassign*) AND (“quality of life”)
